Home Stock

Stock Research: Hisamitsu Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Hisamitsu Pharmaceutical

TSE:4530 JP3784600003
77
  • Value
    94
  • Growth
    20
  • Safety
    Safety
    74
  • Combined
    78
  • Sentiment
    59
  • 360° View
    360° View
    77
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Hisamitsu Pharmaceutical Co Inc is a Japan-based company primarily engaged in the pharmaceutical business, including manufacturing, sales, and supply of pharmaceuticals and related products, and over-the-counter drug (OTC) operations. It also engages in urban cable television broadcasting, Internet connection services, non-life insurance agency, advertising agency, and packing material businesses. The company operates in Japan, the United States, Brazil, Vietnam, Indonesia, Europe, China, and Hong Kong. In the last fiscal year, the company had 2799 employees, a market cap of $2002 million, profits of $606 million, and revenue of $1036 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 77 (better than 77% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Hisamitsu Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Hisamitsu Pharmaceutical. The consolidated Value Rank has an attractive rank of 74, which means that the share price of Hisamitsu Pharmaceutical is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 74% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 94. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 59. But the consolidated Growth Rank has a low rank of 20, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 80 of its competitors have better growth. ...read more

more
Country Japan
Industry Pharmaceuticals
Size Medium
Website hisamitsu.co.jp
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 42 56 59
Growth
20 67 65 33
Safety
Safety
94 86 98 100
Sentiment
59 76 34 90
360° View
360° View
77 92 77 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
19 12 20 24
Opinions Change
98 97 50 99
Pro Holdings
n/a 84 54 86
Market Pulse
73 61 65 65
Sentiment
59 76 34 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
74 42 56 59
Growth
20 67 65 33
Safety Safety
94 86 98 100
Combined
78 81 96 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
61 49 47 58
Price vs. Earnings (P/E)
50 37 45 56
Price vs. Book (P/B)
74 64 67 72
Dividend Yield
78 56 55 60
Value
74 42 56 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
18 34 41 64
Profit Growth
34 63 63 57
Capital Growth
30 59 49 42
Stock Returns
56 76 65 11
Growth
20 67 65 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
81 89 91 88
Refinancing
82 71 81 85
Liquidity
92 82 92 94
Safety Safety
94 86 98 100

Similar Stocks

Discover high‑ranked alternatives to Hisamitsu Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Stanley Electric

TSE:6923
Country: Japan
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Sankyu

TSE:9065
Country: Japan
Industry: Trucking
Size: Medium
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.